B. Rothe et al., EFFECTS OF 5HT(3) RECEPTOR ANTAGONISM BY TROPISETRON ON THE SLEEP EEGAND ON NOCTURNAL HORMONE-SECRETION, Neuropsychopharmacology, 11(2), 1994, pp. 101-106
Two dosages (5 mg and 25 mg) of the selective 5HT(3) receptor antagoni
st tropisetron (ICS 205-930) were administered to healthy male control
s, and the effects on the sleep EEG and nocturnal secretory activity o
f growth hormone (GH) and cortisol were evaluated. The lower dosage wa
s administered to four subjects and the higher dosage to eight on 5 co
nsecutive days, preceded and followed by 2 days of placebo treatment.
After 25 mg of tropisetron, there was a slight increase in REM sleep i
n the first part of the sleep period, and stage 2 was decreased during
the total night. In addition, plasma cortisol levels increased earlie
r than under placebo, and plasma GH levels were reduced in the second
part of the night. Thus, only discrete effects of tropisetron upon sle
ep-endocrine activity were noted, making it unlikely that serotoninerg
ic neurotransmission exerts ifs well-documented effects upon sleep thr
ough 5HT(3) receptors.